This bill establishes a dedicated fund to manage money received from national opioid litigation settlements and appropriates up to $5 million annually for related state police initiatives. It designates the Department of Human Services as the lead agency responsible for distributing these funds to counties and municipalities while ensuring compliance with settlement terms. The legislation also creates a mechanism for the fund to earn interest and allows the department to adopt temporary regulations to oversee the allocation and reporting of these resources.
This bill would grant certified midwives in New Jersey independent authority to prescribe certain drugs, removing the current requirement that they must work under standing orders or practice protocols developed with a collaborating physician. To qualify for this new prescribing power, midwives must complete 30 hours of pharmacology training, including one hour focused on prescription opioid safety and responsible prescribing practices. The State Board of Medical Examiners would oversee the licensing process and has authority to prohibit prescribing privileges if a midwife violates relevant laws or regulations. This change expands midwives' clinical autonomy while maintaining educational standards and oversight mechanisms.
This bill directs New Jersey's Department of Human Services to seek federal approval to offer rental assistance to specific NJ FamilyCare beneficiaries for up to six months. The program would target individuals who are homeless, at risk of homelessness, or transitioning out of emergency shelters and who have been diagnosed with a serious mental illness or substance use disorder. If approved, the state would issue financial assistance vouchers or subsidies directly to housing providers to help eligible recipients secure or maintain housing. The bill also requires the state to adopt new rules and regulations to implement the program once federal permission is granted.
This bill clarifies the New Jersey Department of Human Services' authority to regulate sober living homes and halfway houses as residential substance abuse aftercare facilities. It requires background checks and other safety protections for residents of these facilities to ensure safer living environments for individuals recovering from substance use disorders. The legislation also mandates that the department maintain and publish a public list of all regulated facilities and notify law enforcement agencies of their locations and capacities. By updating existing state laws, the bill aims to standardize oversight and improve accountability for residential treatment facilities across the state.
This bill creates a new Office of Alcohol and Drug Use Disorders Policy within the New Jersey Executive Branch to coordinate statewide efforts related to substance use disorder treatment and prevention. The office will report directly to the Governor and is responsible for reviewing and unifying programs across state, county, and local agencies, while also managing grant distributions to counties and municipalities. Key provisions include the requirement to submit an annual comprehensive master plan, evaluate existing funding mechanisms, collect data for tracking, and convene regular meetings with various state commissioners to improve service coordination. The office will have the authority to request information and resources from any state department to fulfill its duties.
This bill requires all new and existing residential substance use disorder treatment facilities in New Jersey to reserve at least 40 percent of their beds for individuals eligible for NJ FamilyCare, the state's Medicaid program. Facilities must meet this requirement within 12 months of initial licensure or license renewal and maintain it going forward. The Department of Health will not issue or renew licenses for facilities that fail to comply with this bed allocation mandate. The law applies to various types of residential treatment settings, including halfway houses, extended care facilities, and detoxification centers.
This bill requires insurance carriers in New Jersey to cover prescription drugs for serious mental illnesses like schizophrenia, bipolar disorder, and PTSD without requiring prior authorization or step therapy. It directly affects individuals with these conditions who need mental health coverage through health plans, ensuring they can access necessary medications without unnecessary administrative hurdles. The law also mandates that insurers report annually on how they develop medical necessity criteria for mental health and substance use disorder treatments, increasing transparency in coverage decisions. Additionally, carriers must provide information about in-plan exceptions when qualified providers are not available in their network.
This bill allows licensed residential substance use disorder treatment facilities in New Jersey to offer residential mental health services, provided they have a formal contractual agreement with a hospital that offers psychiatric or medical support. The law requires these facilities to maintain joint clinical governance, shared treatment protocols, 24-hour psychiatric and medical consultation availability, and clear procedures for transferring patients to inpatient care when needed. Facilities must file their hospital affiliation agreements with the Department of Health and follow existing state regulations for residential mental health treatment. The measure aims to create a structured pathway for treating individuals with co-occurring mental health and substance use disorders in a sub-acute residential setting that bridges inpatient hospitalization and outpatient care.
This bill requires state agencies that fund or license substance and alcohol use disorder treatment providers to assess them for potential conflicts of interest before approving funding or certification. The assessment process involves reviewing financial statements, board member information, ownership details, and staff outside employment to identify any circumstances that could compromise a provider's judgment. If a conflict is found, the provider must remedy it in writing before receiving funds or licensure, with the reviewing entity holding applications until the issue is resolved. The law applies to all state and local entities that distribute funds or grant certifications to treatment providers and includes a 365-day limit on how often these assessments must be repeated.
This bill amends New Jersey law to allow juveniles (minors under 18) who have been found to have broken the law for drug-related offenses to enter drug court programs instead of facing incarceration, under specific conditions. To qualify, a juvenile must have a documented substance use disorder at the time of the offense, have committed the offense while under the influence or to support their addiction, and meet other criteria like no prior violent offenses or firearm possession. The court must verify these conditions through a professional assessment and ensure appropriate treatment facilities are available before placing the juvenile on special probation. This change expands access to treatment-focused sentencing for eligible juveniles who would otherwise face mandatory incarceration for certain drug offenses.
